Benitec Biopharma Inc (BNTC)
$8.74 -1.02% Close Oct 30, 2026 Live
Benitec Biopharma stock today
Benitec Biopharma closed at $8.74 on October 30, 2026, down 1.02% on the day. Over the past year it returned -45.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $300 million.
$10.00$12.50$15.00
NovJan 2026MarMayJulSep
| Period | BNTC | S&P 500 (SPY) |
|---|---|---|
| 1 month | -12.6% | -0.9% |
| 3 months | -26.3% | +2.1% |
| Year to date | -35.1% | +11.7% |
| 1 year | -45.9% | +12.4% |
| 3 years | +146.2% | +88.5% |
| 5 years | -86.0% | +76.0% |
Key statistics
- Market value
- $300M
- 52-week range
- $8.11 to $16.36
- Next report
- Nov 12, 2026 (estimated)
About Benitec Biopharma
Develops gene silencing therapies using RNA interference technology.
Sector: Health Care
More on Benitec Biopharma
- Financials: revenue, earnings and segmentsRevenue +3% in the year to Jun 2023
- Returns: what $1,000 became$1,000 ten years ago is $21.72 today
No forecast, no recommendation. This page describes Benitec Biopharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.